Join us at the 5th REMS Innovation Summit on July 15-16, 2025, in Washington, D.C., where we’ll explore the evolving role of Risk Evaluation and Mitigation Strategies (REMS) in drug safety.
REMS are specialized safety programs mandated by the FDA for specific medications with serious safety concerns, ensuring their benefits outweigh potential risks. Unlike standard medication labeling, REMS reinforce behaviors and conditions that support safe medication use, helping reduce the occurrence and severity of specific risks.
This year’s summit will feature in-depth sessions and case studies, focusing on how REMS programs are shaping safer drug use practices across healthcare.
Don’t miss this opportunity to connect with industry leaders and peers dedicated to advancing medication safety. Mark your calendars for July 15-16, 2025, and join us in Washington, D.C.!
2024 TESTIMONIALS
2024 Speaking
Faculty
Josue Bautista Arteaga
Kal Elhoregy
Garry Flounders
Jacqueline Gerena
Bill Haddock
Catina O’Leary
Maha Saad
Sameer Thapar
Thank you to our 2025 sponsor
Gold Sponsor
2025 Sponsorship Opportunities are Open
Sponsorship is a great way to enhance your brand’s visibility and help you connect with top-level decision-makers, innovators, and industry disruptors. There are a number of ways to maximize branding opportunities at the summit.
Top Reasons to Attend
Who should attend?
This event is designed for pharmaceutical, biotech, and medical device professionals with responsibilities in the following areas:
- Benefit/Risk Management
- Medical Direction
- Quality Assurance
- Real-World Evidence Generation
- Clinical Risk Management
- Life Cycle Management
- Regulatory Affairs/Legal/Compliance
- Clinical Research
- Clinical Risk Management Compliance
- Epidemiology/ Pharmacoepidemiology